Client Transactions

The Harvard Drug Group

July 6, 2015 Piper Jaffray co-advises The Harvard Drug Group on $1.1 billion sale to Cardinal Health.

 

Austin Community College District

December 3, 2014Piper Jaffray serves as senior manager for $13.7 million combined fee revenue refunding bonds.

Recent News

August 17, 2015 Former Ceridian CEO Stuart C. Harvey Jr. appointed Piper Jaffray merchant banking partner

August 6, 2015 Piper Jaffray announces share repurchase authorization